In Press Release

Vancouver, British Columbia – October 17, 2018 – NeutriSci International Inc. (“NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy® and Nutritional High International Inc. (“Nutritional High”) (CSE: EAT, OTCQB: SPLIF, FRANKFURT: 2NU) are pleased to provide a further update on their previously announced partnership.

The initial production run for the newly developed chewable, sublingual cannabis product (“NU Tablets”) for distribution and sale n the state of California, is on track and underway at Nutritional High’s FLI NorCal facility in Sacramento, California. Delivery of the first purchase orders are set for November 2018. Initial distribution by Nutritional High’s distributor, Calyx, will begin to approximately 450 plus dispensaries across the state of California. Unveiling of the finished packaging and branding will be released prior to the first shipment to dispensaries.

NU Tablet product SKU (stock keeping unit) selections include varying flavor profiles for Sativa, Indica and a Hybrid, with each product SKU containing different amounts of cannabis, combined with NeutriSci’s Cryolisation technology. The combination of NeutriSci’s IP and ingredients with Nutritional High’s cannabis distillate makes this product a first-of-its-kind. This ground-breaking product provides a measured and effective dose with the added health benefits and increased bio-availability of pterostilbene.

Retail pricing for the NU Tablets are being set by the dispensaries and will be consistent with pricing for other edible delivery forms of products with similar volumes of cannabis, which range from USD$26.00-$32.00 per unit.

Jim Frazier, CEO of Nutritional High commented, “We are pleased to add the NeutriSci Tablets to our product mix. While caffeine isn’t permitted to be sold with THC, NeutriSci’s proprietary all-natural products are ideal to allow customers a unique cannabis experience and energy boost. Next stop: Las Vegas!”

NeutriSci’s CEO, Glen Rehman stated, “We are very pleased to announce that manufacturing of the new sublingual melts using NeutriSci’s patent pending Cryolisation technology is underway with expected delivery and sales to begin as soon as the initial run is completed. We are confident that the relationship we have built with Nutritional High, along with the processes that have been put in place, will be able to handle the volumes of what we expect to be a very well received product. We are very excited to have California be the lead state for this product launch and look forward to adding more states in the days to come.”

NeutriSci also announces that it has granted a total of 3,225,000 incentive stock options to certain directors, officers, employees and consultants of NeutriSci. The options have an exercise price of $0.175 and expire in five years.

On Behalf of the Board of Directors of


Glen Rehman
CEO & President
Tel: (403) 264-6320



David Posner
Co-Chairman of the Board
Tel: (647) 985-6727


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking.  Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements.  Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions.  There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties.  We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

About NeutriSci International Inc.

NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci’s is building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy®, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries.

Neuenergy® contains a unique patented combination of blueberry extract (pterostilbene) and naturally derived caffeine, and is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products. To find out more about neuenergy®, please visit

For more information, please visit:

About Nutritional High International Inc.

Nutritional High is focused on developing, manufacturing and distributing products under recognized brands in the cannabis products industry, with a specific focus on edibles and oil extracts for medical and adult recreational use. The Company works exclusively through licensed facilities in jurisdictions where such activity is permitted and regulated by state law.

The Company follows a vertically integrated model with a fully developed strategy for acquisitions in extraction, production, sales, and distribution sectors of the cannabis industry. Nutritional High has brought its flagship FLÏ™ edibles and extracts product line from production to market in California through its wholly owned distributor Calyx Brands Inc., and Colorado where its products are manufactured by a licensed producer. The Company also owns a 50% interest in The Clinic Effingham (an Illinois dispensary), and is entering the Nevada, Washington State, Oregon and Canadian markets in the near future.

For updates on the Company’s activities and highlights of the Company’s press releases and other media coverage, please follow Nutritional High on Facebook, Twitter, Instagram and Google+ or visit

Statements in this press release have not been evaluated by the Food and Drug Administration.  Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

Recommended Posts
Contact Us

Send us a message and we'll get back to you as soon as possible.

Not readable? Change text. captcha txt

Start typing and press Enter to search